{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:19:08Z","timestamp":1791944348052,"version":"4.3.4"},"reference-count":122,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T00:00:00Z","timestamp":1249257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Anti\u2010Tumour necrosis factor (TNF) therapy is now well established in the treatment of inflammatory bowel disease and the risk of opportunistic infection is recognized. However, specific considerations regarding screening, detection, prevention and treatment of chronic viral infections in the context of anti\u2010TNF therapy in inflammatory bowel disease are not widely adopted in practice.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To provide a detailed and comprehensive review of the relevance of chronic viral infections in the context of anti\u2010TNF therapy in inflammatory bowel disease.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Literature search was conducted using Medline, Pubmed and Embase using the terms viral infection, hepatitis, herpes, CMV, EBV, HPV, anti\u2010TNF, infliximab, adalimumab, certolizumab pegol and etanercept. Hepatitis B and C and HIV had the largest literature associated and these have been summarized in Tables.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Particular risks are associated with the use of anti\u2010TNF drugs in patients with hepatitis B infection, in whom reactivation is common unless anti\u2010viral prophylaxis is used. Reactivation of herpes zoster is the most common viral problem associated with anti\u2010TNF treatment, and may be particularly severe. Primary varicella infection may present with atypical features in patients on anti\u2010TNF.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Appreciation of risks of chronic viral disease associated with anti\u2010TNF therapy may permit early recognition, prophylaxis and treatment.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2009.04112.x","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T16:25:20Z","timestamp":1249316720000},"page":"20-34","source":"Crossref","is-referenced-by-count":84,"title":["Review article: chronic viral infection in the anti\u2010tumour necrosis factor therapy era in inflammatory bowel disease"],"prefix":"10.1111","volume":"31","author":[{"given":"M. J.","family":"SHALE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. H.","family":"SEOW","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. S.","family":"COFFIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. G.","family":"KAPLAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"PANACCIONE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"GHOSH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08512-4"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.030"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011110"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200409000-00025"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10758"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21513"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20119"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.05.027"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.070763"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290123"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80295-2"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200409000-00035"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.7.686"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.040675"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i6.974"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-1295-8"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.031187"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21216"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0392-1"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20035"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20216"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2007.01665.x"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-008-2165-x"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e318181b89d"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep003"},{"key":"e_1_2_9_27_2","first-page":"1624","article-title":"Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset Still\u2019s disease","volume":"30","author":"Michel M","year":"2003","journal-title":"J Rheumatol"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1149-4"},{"key":"e_1_2_9_29_2","first-page":"421","article-title":"Short\u2010term course of chronic hepatitis B and C under treatment with etanercept associated with different disease modifying antirheumatic drugs without antiviral prophylaxis","volume":"35","author":"Cansu DU","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-008-0896-y"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.028209"},{"key":"e_1_2_9_32_2","first-page":"107","article-title":"Infliximab therapy for rheumatic diseases in patients with chronic hepatitis B or C","volume":"31","author":"Oniankitan O","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel123"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2009.02.010"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.114660"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.08.030"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.100834"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.07.014"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199907013410104"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20202"},{"issue":"1","key":"e_1_2_9_41_2","first-page":"S3","article-title":"EASL International Consensus Conference on Hepatitis B. Consensus Statement","volume":"39","author":"De Franchis R","year":"2003","journal-title":"J Hepatol"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1996.tb00768.x"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199611270-00007"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200102000-00016"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20702"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07245.x"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.05.013"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0394-z"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel191"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.11.1078"},{"key":"e_1_2_9_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21949"},{"key":"e_1_2_9_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.05.043"},{"key":"e_1_2_9_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.11.1035"},{"key":"e_1_2_9_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2008.03619.x"},{"key":"e_1_2_9_55_2","first-page":"4","article-title":"Psoriasis and hepatitis C treated with anti\u2010TNF alpha therapy (etanercept)","volume":"12","author":"Cecchi R","year":"2006","journal-title":"Dermatol Online J"},{"key":"e_1_2_9_56_2","first-page":"1944","article-title":"Safety of anti\u2010tumor necrosis factor\u2010alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection","volume":"35","author":"Ferri C","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_9_57_2","first-page":"1353","article-title":"Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection","volume":"34","author":"Linardaki G","year":"2007","journal-title":"J Rheumatol"},{"key":"e_1_2_9_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.05.002"},{"key":"e_1_2_9_59_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01131.x"},{"key":"e_1_2_9_60_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0412-1"},{"key":"e_1_2_9_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02693.x"},{"key":"e_1_2_9_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.025"},{"key":"e_1_2_9_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07539.x"},{"key":"e_1_2_9_64_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.42.6.856"},{"key":"e_1_2_9_65_2","first-page":"290","article-title":"Effects of tumor necrosis factor antagonist treatment on hepatitis C\u2010related immunological abnormalities","volume":"17","author":"Vauloup C","year":"2006","journal-title":"Eur Cytokine Netw"},{"key":"e_1_2_9_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03779.x"},{"key":"e_1_2_9_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(89)80213-X"},{"key":"e_1_2_9_68_2","doi-asserted-by":"publisher","DOI":"10.4065\/75.10.1093"},{"key":"e_1_2_9_69_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.1.63"},{"key":"e_1_2_9_70_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200401230-00015"},{"key":"e_1_2_9_71_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.101386"},{"key":"e_1_2_9_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2006.05.012"},{"key":"e_1_2_9_73_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.16.1783"},{"key":"e_1_2_9_74_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.081513"},{"key":"e_1_2_9_75_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.rhu.0000260411.75599.39"},{"key":"e_1_2_9_76_2","first-page":"407","article-title":"Infliximab in the treatment of an HIV positive patient with Reiter\u2019s syndrome","volume":"30","author":"Gaylis N","year":"2003","journal-title":"J Rheumatol"},{"key":"e_1_2_9_77_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0007-0963.2004.05885.x"},{"key":"e_1_2_9_78_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.144.4.453"},{"key":"e_1_2_9_79_2","first-page":"1","article-title":"Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation","volume":"49","author":"CDC","year":"2000","journal-title":"MMWR"},{"key":"e_1_2_9_80_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-5_Part_2-200209031-00002"},{"key":"e_1_2_9_81_2","doi-asserted-by":"publisher","DOI":"10.1038\/323819a0"},{"key":"e_1_2_9_82_2","unstructured":"US Food and Drug Administration Center for Drug Evaluation and Research Website [Accessed July 28th 2008] (Available at:http:\/\/www.fda.gov\/cder\/aers\/extract.htm)"},{"key":"e_1_2_9_83_2","first-page":"S58","article-title":"Disseminated herpes simplex (HSV) infection precipitating macrophage activation syndrome (MAS) in a child with systemic juvenile idiopathic arthritis (SJIA) undergoing therapy with infliximab [abstract]","volume":"1","author":"Skripak JM","year":"2003","journal-title":"Pediatr Rheumatol Online J"},{"key":"e_1_2_9_84_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-003-1867-z"},{"key":"e_1_2_9_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2007.10.011"},{"key":"e_1_2_9_86_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.146"},{"key":"e_1_2_9_87_2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000149311","article-title":"Recurrent varicella in an adult psoriasis patient treated with etanercept","volume":"217","author":"Becart S","year":"2008","journal-title":"Dermatology"},{"key":"e_1_2_9_88_2","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.2003.014373"},{"key":"e_1_2_9_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.10.002"},{"key":"e_1_2_9_90_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01984.x"},{"key":"e_1_2_9_91_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2006.02779.x"},{"key":"e_1_2_9_92_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.41389_7.x"},{"key":"e_1_2_9_93_2","first-page":"2517","article-title":"Disseminated primary varicella infection during infliximab treatment","volume":"31","author":"Vonkeman H","year":"2004","journal-title":"J Rheumatol"},{"key":"e_1_2_9_94_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.2912"},{"key":"e_1_2_9_95_2","doi-asserted-by":"publisher","DOI":"10.1086\/500262"},{"key":"e_1_2_9_96_2","doi-asserted-by":"publisher","DOI":"10.1086\/425123"},{"key":"e_1_2_9_97_2","doi-asserted-by":"publisher","DOI":"10.1086\/428672"},{"key":"e_1_2_9_98_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200212000-00018"},{"key":"e_1_2_9_99_2","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20131"},{"key":"e_1_2_9_100_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh696"},{"key":"e_1_2_9_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2008.06.002"},{"issue":"10","key":"e_1_2_9_102_2","first-page":"59","article-title":"Epstein\u2013Barr virus and lymphoproliferative disorders after transplantation","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"issue":"10","key":"e_1_2_9_103_2","first-page":"95","article-title":"Human papillomavirus infection","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"issue":"1","key":"e_1_2_9_104_2","first-page":"A144","article-title":"Risk of lymphoma associated with anti\u2010TNF agents for the treatment of Crohn\u2019s disease: A meta\u2010analysis","volume":"134","author":"Siegel CA","year":"2008","journal-title":"Gastroenterology"},{"key":"e_1_2_9_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.03.002"},{"key":"e_1_2_9_106_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10679"},{"key":"e_1_2_9_107_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22579"},{"key":"e_1_2_9_108_2","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-008-0053-0"},{"key":"e_1_2_9_109_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-007-0467-6"},{"key":"e_1_2_9_110_2","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200403000-00004"},{"key":"e_1_2_9_111_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22783"},{"key":"e_1_2_9_112_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200305000-00007"},{"key":"e_1_2_9_113_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01582.x"},{"key":"e_1_2_9_114_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.10.021"},{"key":"e_1_2_9_115_2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2036.2008.03766.x","article-title":"Screening differences and risk of cervical cancer in inflammatory bowel disease","volume":"28","author":"Fireman B","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"e_1_2_9_116_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2003.009332"},{"key":"e_1_2_9_117_2","doi-asserted-by":"publisher","DOI":"10.1159\/000117709"},{"key":"e_1_2_9_118_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.7.684"},{"key":"e_1_2_9_119_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.16.3.357-364.2003"},{"key":"e_1_2_9_120_2","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200409000-00028"},{"key":"e_1_2_9_121_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00646.x"},{"key":"e_1_2_9_122_2","first-page":"272","article-title":"Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab","volume":"34","author":"Kaine JL","year":"2007","journal-title":"J Rheumatol"},{"key":"e_1_2_9_123_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.01.012"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2009.04112.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2009.04112.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:08:19Z","timestamp":1698782899000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2009.04112.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,2]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1111\/j.1365-2036.2009.04112.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04112.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,2]]}}}